ARX 1.90% 53.5¢ aroa biosurgery limited

News: ARX Aroa Biosurgery Says Preliminary Unaudited FY23 Normalised EBITDA Positive

  1. 193,698 Posts.
    lightbulb Created with Sketch. 2825

    April 27 (Reuters) - Aroa Biosurgery (ARX) :

    • PRELIMINARY UNAUDITED FY23 FULL YEAR NORMALISED EBITDA POSITIVE
    • PRELIM UNAUDITED FY23 TOTAL REVENUE ABOUT NZ$63.4 MILLION, GROWTH OF 60%
 
watchlist Created with Sketch. Add ARX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.